by Heaton Acupuncture | Jan 5, 2021 | Acupuncture, Breast Cancer, Hot Flushes
A network meta-analysis comparing non-hormonal treatments suggested that acupuncture was the most effective therapy at improving hot flushes in breast cancer survivors. Chinese authors analysed data from 16 RCTs involving 2,349 participants. Acupuncture was...
by Heaton Acupuncture | May 25, 2017 | Acupuncture, Breast Cancer, Electro-Acupuncture
The effects of electro-acupuncture (EA) are comparable with those of the drug gabapentin (GP) for improving sleep disturbances among breast cancer survivors. American investigators analysed data from a randomised trial involving 58 breast cancer survivors who were...
by Heaton Acupuncture | Feb 14, 2017 | Acupuncture, Breast Cancer, Hot Flushes
Acupuncture seems to be an effective therapy for hot flushes (HFs) experienced by women with breast cancer (BC), according to a Chinese systematic review. The authors examined data from 12 RCTs (672 women) comparing manual acupuncture and electro-acupuncture with a...
by Heaton Acupuncture | Jul 5, 2016 | Acupuncture, Breast Cancer, Hot Flushes
Acupuncture in association with enhanced self-care is an effective integrative intervention for managing hot flushes and improving quality of life in women with breast cancer, according to Italian researchers. A pragmatic, randomised controlled trial compared...
by Heaton Acupuncture | Jul 5, 2016 | Breast Cancer, Chemotherapy, Qigong
A preliminary study from Taiwan suggests that both static and moving forms of qigong practice are beneficial for breast cancer patients undergoing chemotherapy. A quasi-experimental design was applied to the study of 95 females who were receiving chemotherapy for...
by Heaton Acupuncture | Mar 3, 2016 | Acupuncture, Breast Cancer, Cancer, Electro-Acupuncture, Hot Flushes
An American study suggests that electro-acupuncture (EA) may be more effective for managing hot flushes among breast cancer survivors than the drug gabapentin (GP), with fewer adverse effects. The randomised controlled trial involved 120 survivors of breast cancer who...